ArticleCancer chemotherapy and pharmacology2024

Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study.

Carla Biesdorf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.